Implementing biocatalytic strategies in an industrial setting is a challenging task, especially when commercial scale necessitates a balance between industrial need and economic viability. With invited contributions from a wide range of chemical and pharmaceutical companies, this book bridges the gap between academia and industry. Contributors discuss current processes, types of biocatalysts and improvements, industrial motivation and the key aspects needed for economic success. Focussing on industry related issues, this book will be a useful tool for future research by both practitioners and academics.…mehr
Implementing biocatalytic strategies in an industrial setting is a challenging task, especially when commercial scale necessitates a balance between industrial need and economic viability. With invited contributions from a wide range of chemical and pharmaceutical companies, this book bridges the gap between academia and industry. Contributors discuss current processes, types of biocatalysts and improvements, industrial motivation and the key aspects needed for economic success. Focussing on industry related issues, this book will be a useful tool for future research by both practitioners and academics.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
An Appreciation of Biocatalysis in the Swiss Manufacturing Environment; Biocatalysis - A greener alternative in synthetic chemistry; Biocatalysis synthesis of small molecules - Past, present and future; EntreChem: Building a sustainable business case in biotechnology: from biocatalysis to synthetic biology; Bristol-Myers Squibb: Preparation of chiral intermediates for the development of drugs and API's; Johnson Matthey: A technology provider perspective to biocatalysis in the fine chemicals industry; EnzymeWorks: Recent advance in enzyme engineering for chemical synthesis; Almac: Scalable reduction and oxidation catalysis using ene-reductase enzymes; GSK: Biocatalyst discovery and optimization; PETROBRAS: Efforts on biocatalysis for fuels and chemicals production; Metgen: Value from Wood - Enzymatic Solutions; LentiKat's: Industrial Biotechnology, Experiences and Visions; EnginZyme: Universal Enzyme Immobilization; Cross-linked Enzyme Aggregates (CLEAs): from Concept to Industrial Biocatalyst; SynBiocat: Protein purification, immobilization and continuous-flow processes; Microvi: MicroNiche EngineeringTM for Biocatalysis in the Water and Chemical Industries; Nofima: Peptide recovery and commercialization by enzymatic hydrolysis of marine biomass; CO2 Solutions: A biomimetic approach to mitigate CO2 Emissions - The use of Carbonic Anhydrase in an "Industrial Lung"
An Appreciation of Biocatalysis in the Swiss Manufacturing Environment; Biocatalysis - A greener alternative in synthetic chemistry; Biocatalysis synthesis of small molecules - Past, present and future; EntreChem: Building a sustainable business case in biotechnology: from biocatalysis to synthetic biology; Bristol-Myers Squibb: Preparation of chiral intermediates for the development of drugs and API's; Johnson Matthey: A technology provider perspective to biocatalysis in the fine chemicals industry; EnzymeWorks: Recent advance in enzyme engineering for chemical synthesis; Almac: Scalable reduction and oxidation catalysis using ene-reductase enzymes; GSK: Biocatalyst discovery and optimization; PETROBRAS: Efforts on biocatalysis for fuels and chemicals production; Metgen: Value from Wood - Enzymatic Solutions; LentiKat's: Industrial Biotechnology, Experiences and Visions; EnginZyme: Universal Enzyme Immobilization; Cross-linked Enzyme Aggregates (CLEAs): from Concept to Industrial Biocatalyst; SynBiocat: Protein purification, immobilization and continuous-flow processes; Microvi: MicroNiche EngineeringTM for Biocatalysis in the Water and Chemical Industries; Nofima: Peptide recovery and commercialization by enzymatic hydrolysis of marine biomass; CO2 Solutions: A biomimetic approach to mitigate CO2 Emissions - The use of Carbonic Anhydrase in an "Industrial Lung"
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
Wir verwenden Cookies und ähnliche Techniken, um unsere Website für Sie optimal zu gestalten und Ihr Nutzererlebnis fortlaufend zu verbessern. Ihre Einwilligung durch Klicken auf „Alle Cookies akzeptieren“ können Sie jederzeit widerrufen oder anpassen. Bei „Nur notwendige Cookies“ werden die eingesetzten Techniken, mit Ausnahme derer, die für den Betrieb der Seite unerlässlich sind, nicht aktiviert. Um mehr zu erfahren, lesen Sie bitte unsere Datenschutzerklärung.
Notwendige Cookies ermöglichen die Grundfunktionen einer Website (z. B. Seitennavigation). Sie können nicht deaktiviert werden, da eine technische Notwendigkeit besteht.
Funktionale Cookies sorgen für ein komfortables Nutzererlebnis und speichern z. B. ob Sie eingeloggt bleiben möchten. Diese Arten von Cookies dienen der „Wiedererkennung“, wenn Sie unsere Website besuchen.
Wir nutzen Marketing Cookies, um die Relevanz unserer Seiten und der darauf gezeigten Werbung für Sie zu erhöhen und auf Ihre Interessen abzustimmen. Zu diesem Zweck teilen wir die Daten auch mit Drittanbietern.